Half of patients undergoing cerebrovascular stent placement did not respond well to clopidogrel, according to a new study. Clopidogrel and aspirin are medications routinely prescribed for one to three months following cerebrovascular stent placement to combat the risk of blood clots (stent-thrombosis) and reclosure of the artery (re-stenosis).
More...